Cancer Prevention in Germany: Overcoming Barriers Amid Advances

Cancer prevention in Germany faces significant challenges despite notable advances and promising innovations in the field. Experts emphasize the economic and health potential of prevention strategies, yet implementation remains slow due to political and structural obstacles. Prof. Dr. Michael Baumann, chairman of the German Cancer Research Center (DKFZ), stresses that establishing the necessary political and structural conditions is essential for translating cancer prevention knowledge into practical healthcare improvements.

The German Society for Hematology and Medical Oncology (DGHO) highlights the importance of prevention and early detection, with many cancers being potentially preventable or detectable at earlier stages. At their recent spring conference and the forthcoming annual meeting in Vienna, the DGHO underscored these priorities as crucial future tasks for the healthcare system. Prof. Dr. Claudia Baldus, managing chair of DGHO, pointed out that improving data availability and linkage, along with enhanced research funding, are critical to advancing prevention.

Further blurring the traditional lines between prevention, early detection, diagnostics, and therapy, Prof. Dr. Maike de Wit notes that new diagnostic technologies enable more precise risk assessments and pave the way for personalized early treatment strategies. A notable example is the introduction of lung cancer screening for defined high-risk groups in Germany, marking a positive development.

These advances underscore the growing significance of aftercare, quality of life, and survivorship in cancer medicine. Still, the full potential of prevention awaits overcoming existing systemic barriers to widescale implementation, requiring coordinated efforts across political, medical, and research sectors.